RS51051B - Heksaciklična jedinjenja - Google Patents
Heksaciklična jedinjenjaInfo
- Publication number
- RS51051B RS51051B YUP-470/04A YUP47004A RS51051B RS 51051 B RS51051 B RS 51051B YU P47004 A YUP47004 A YU P47004A RS 51051 B RS51051 B RS 51051B
- Authority
- RS
- Serbia
- Prior art keywords
- alkylamino
- alkoxy
- amino
- mono
- hydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 5
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006715 (C1-C5) alkylthio group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Heksaciklično jedinjenje formule [1]naznačeno time štoZ je -NH-C(=X)-N(R1)- ili -N=C(R2)-N(R1)-; R1 je vodonik;(C1-C10) alikl, po potrebi supstituisan sa jednom do tri grupe nezavisno odabrane iz grupe koja se sastoji od (C1-C5) alkoksi, hidroksi, halogen, amino, mono-(C1-C5) alkilamino, di-(C1-C5) alkilamino i (C3-C7) cikloalkil, heterocikličnog prstena i aril u kojem je aril prsten po potrebi supstituisan sa jednom do tri grupe nezavisno odabrane od grupe koja se sastoji od hidroksi, alkoksi, halogen, amino, mono-(C1-C5) alkilamino i di-(C1-C5) alkilamino;R2 je vodonik; amino; (C1-C5) alikl, (C1-C5) alkoksi, (C1-C5) alkiltio, mono-(C1-C5) aliklamino, di-(C1-C5) alkilamino, po potrebi supstituisan sa jednom do tri grupe nezavisno odabrane od grupe koja se sastoji od (C1-C5) alkoksi, hidroksi, halogen, amino, (C3-C7) cikloalkil, heterocikličnog prstena i aril u kojem je aril prsten po potrebi supstituisan sa jednom do tri grupe nezavisno odabrane od grupe koja se sastoji od hidroksi, (C1-C5) alkoksi, amino, mono-(C1-C5) alkilamino ili di-(C1-C5) alkilamino;R3 i R4 su nezavisno vodonik, halogen ili (C1-C5) alkil; iX je kiseonik ili sumpor;i njegove farmaceutski prihvatljive soli. Prijava sadrži još 27 patentnih zahteva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01128361 | 2001-11-30 | ||
| PCT/EP2002/013216 WO2003045952A2 (en) | 2001-11-30 | 2002-11-25 | Condensed camptothecins as antitumor agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RS47004A RS47004A (en) | 2007-02-05 |
| RS51051B true RS51051B (sr) | 2010-10-31 |
Family
ID=8179394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YUP-470/04A RS51051B (sr) | 2001-11-30 | 2002-11-25 | Heksaciklična jedinjenja |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6825194B2 (sr) |
| EP (1) | EP1480984B9 (sr) |
| JP (1) | JP4305909B2 (sr) |
| KR (1) | KR100895746B1 (sr) |
| CN (1) | CN100338066C (sr) |
| AT (1) | ATE398131T1 (sr) |
| AU (1) | AU2002356720B2 (sr) |
| BR (1) | BR0214615A (sr) |
| CA (1) | CA2468824C (sr) |
| DE (1) | DE60227113D1 (sr) |
| ES (1) | ES2307830T3 (sr) |
| GT (1) | GT200200250A (sr) |
| HK (2) | HK1072935A1 (sr) |
| HU (1) | HUP0500062A3 (sr) |
| IL (1) | IL162058A0 (sr) |
| MX (1) | MXPA04005185A (sr) |
| MY (1) | MY136138A (sr) |
| NO (1) | NO329005B1 (sr) |
| NZ (1) | NZ533568A (sr) |
| PA (1) | PA8558901A1 (sr) |
| PE (1) | PE20030725A1 (sr) |
| PL (1) | PL207510B1 (sr) |
| RS (1) | RS51051B (sr) |
| RU (1) | RU2299212C2 (sr) |
| TW (1) | TWI258481B (sr) |
| UA (1) | UA80409C2 (sr) |
| UY (1) | UY27560A1 (sr) |
| WO (1) | WO2003045952A2 (sr) |
| ZA (1) | ZA200404522B (sr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1777611A (zh) * | 2003-02-21 | 2006-05-24 | 中外制药株式会社 | 制备六环喜树碱衍生物的方法 |
| KR20070011457A (ko) | 2004-04-09 | 2007-01-24 | 추가이 세이야쿠 가부시키가이샤 | 신규 수용성 프로드럭 |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| AU2006305169A1 (en) * | 2005-10-19 | 2007-04-26 | Chugai Seiyaku Kabushiki Kaisha | Preventive or therapeutic agents for pancreatic cancer, ovarian cancer, or liver cancer comprising a novel water-soluble prodrug |
| DK3946464T3 (da) | 2019-03-29 | 2022-10-31 | Medimmune Ltd | Forbindelser og konjugater deraf |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4473692A (en) | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
| US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| HU213136B (en) * | 1990-08-14 | 1997-02-28 | Kyorin Seiyaku Kk | Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them |
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| JP3359955B2 (ja) * | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
| GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
| US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| AU6272598A (en) | 1997-02-14 | 1998-09-08 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| GB9715821D0 (en) * | 1997-07-25 | 1997-10-01 | Pharmacia & Upjohn Spa | Amidino-camptothecin derivatives |
-
2002
- 2002-11-25 BR BR0214615-0A patent/BR0214615A/pt not_active IP Right Cessation
- 2002-11-25 EP EP02803790A patent/EP1480984B9/en not_active Expired - Lifetime
- 2002-11-25 WO PCT/EP2002/013216 patent/WO2003045952A2/en active IP Right Grant
- 2002-11-25 RU RU2004119841/04A patent/RU2299212C2/ru not_active IP Right Cessation
- 2002-11-25 IL IL16205802A patent/IL162058A0/xx not_active IP Right Cessation
- 2002-11-25 CA CA2468824A patent/CA2468824C/en not_active Expired - Fee Related
- 2002-11-25 UA UA20040605013A patent/UA80409C2/uk unknown
- 2002-11-25 MX MXPA04005185A patent/MXPA04005185A/es active IP Right Grant
- 2002-11-25 HU HU0500062A patent/HUP0500062A3/hu unknown
- 2002-11-25 CN CNB028277465A patent/CN100338066C/zh not_active Expired - Fee Related
- 2002-11-25 KR KR1020047008223A patent/KR100895746B1/ko not_active IP Right Cessation
- 2002-11-25 ES ES02803790T patent/ES2307830T3/es not_active Expired - Lifetime
- 2002-11-25 NZ NZ533568A patent/NZ533568A/en not_active IP Right Cessation
- 2002-11-25 AU AU2002356720A patent/AU2002356720B2/en not_active Ceased
- 2002-11-25 DE DE60227113T patent/DE60227113D1/de not_active Expired - Lifetime
- 2002-11-25 AT AT02803790T patent/ATE398131T1/de not_active IP Right Cessation
- 2002-11-25 JP JP2003547402A patent/JP4305909B2/ja not_active Expired - Fee Related
- 2002-11-25 PL PL370479A patent/PL207510B1/pl not_active IP Right Cessation
- 2002-11-25 RS YUP-470/04A patent/RS51051B/sr unknown
- 2002-11-26 US US10/304,672 patent/US6825194B2/en not_active Expired - Fee Related
- 2002-11-27 TW TW091134463A patent/TWI258481B/zh not_active IP Right Cessation
- 2002-11-28 PE PE2002001148A patent/PE20030725A1/es not_active Application Discontinuation
- 2002-11-28 PA PA20028558901A patent/PA8558901A1/es unknown
- 2002-11-28 MY MYPI20024479A patent/MY136138A/en unknown
- 2002-11-29 UY UY27560A patent/UY27560A1/es not_active Application Discontinuation
- 2002-11-29 GT GT200200250A patent/GT200200250A/es unknown
-
2004
- 2004-06-08 ZA ZA200404522A patent/ZA200404522B/en unknown
- 2004-06-29 NO NO20042729A patent/NO329005B1/no not_active IP Right Cessation
- 2004-09-16 US US10/942,044 patent/US7109195B2/en not_active Expired - Fee Related
-
2005
- 2005-05-30 HK HK05104506A patent/HK1072935A1/xx not_active IP Right Cessation
- 2005-10-21 HK HK05109380A patent/HK1077303A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20000854B1 (en) | Therapeutic biaryl derivatives | |
| HRP20080113T3 (en) | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | |
| ATE282614T1 (de) | Phenylharnstoff und phenylthioharnstoffderivate | |
| HRP20070529T3 (en) | Imidazole derivatives as glutmate receptor antagonists | |
| CO5070570A1 (es) | DERIVADOS DE TIROSINA COMO ACTIVADORES DE hPPAR Y hPPARalfa Y UNA COMPOSICION FARMACEUTICA QUE LOS CONTIENE | |
| ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
| HRP20030791B1 (en) | DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS mGluR2 ANTAGONISTS I | |
| HRP20050628A2 (en) | Substituted benzoyl derivatives uses as herbicides | |
| HRP20040429B1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
| HRPK20040293B3 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
| ATE497948T1 (de) | Bicyclische verbindungen | |
| AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
| RS51051B (sr) | Heksaciklična jedinjenja | |
| HUP0203275A2 (hu) | 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása | |
| DE69732635D1 (de) | Cis-substituierte aminocyclopropanderivate | |
| DK1899331T3 (da) | Homomorpholinoxazolidnoner som antibakterielle midler | |
| MEP12108A (en) | Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them | |
| DE69914803D1 (de) | Benzoxazol-derivate zur verwendung als integrin-inhibitoren | |
| NO20053302D0 (no) | Imidazolderivater med affinitet for alfa 2-reseptoraktivitet. | |
| MY133207A (en) | Substituted benzolactam compaunds | |
| ATE223907T1 (de) | Arginnin analoge mit no- syntax inhibierenderwirkung | |
| HUP0204168A2 (hu) | Butin-diol-származékok, ilyeneket tartalmazó gyógyszerkészítmény és előállítása | |
| ATE275133T1 (de) | 1,2-dihydro-2-oxochinolin-derivate | |
| DE60239491D1 (de) | Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung | |
| YU67096A (sh) | Farmaceutska jedinjenja |